Korro Bio Inc. (KRRO) - Utang marang Ekuitas

Lambang korporat lan logo Korro Bio, Inc. (KRRO)

Korro Bio, Inc. (KRRO) is implementing automated laboratory systems to accelerate the screening of anti-tumor agents. The business model relies on venture capital investments and technological leaps in therapy rather than macroeconomics. The total debt-to-equity ratio stands at 0.39, which the price action on this chart links to high margins driven by a global network of biopharma contractors and the complex cold-chain logistics of RNA products.

KRRO: Total Utang marang Modal Korro Bio, Inc 21.02.2024 - 29.10.2026

Rincian metrik komprehensif lan analitis Korro Bio (KRRO)

- rega lan prakiraan konsensus rega:
Rega saham Korro Bio Inc.|KRRO - Prakiraan gabungan firma investasi
- data kapitalisasi pasar:
Nilai pasar Korro Bio|KRRO - Nilai Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham Korro Bio|KRRO - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku korrobio.com|KRRO - Total Aset Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas Korro Bio, Inc.|KRRO - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Korro Bio Inc.|KRRO - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Korro Bio|KRRO - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Korro Bio
Ringkesan analisis perusahaan:KRRO - Korro Bio, Inc.
Sampel barang Korro Bio Inc.

Investors expect high capitalization with minimal liabilities from biotech startups. This indicator is calculated as the ratio of total borrowed funds to equity. By analyzing changes in the total debt-to-equity ratio, one can assess the degree of financial leverage and the risk of bankruptcy. For Korro Bio, Inc. (KRRO) and its OPERA platform, low leverage is critically important during the lengthy development of RNA drugs. The stability of this ratio confirms the sustainability of innovation funding.

Pesaing wigati

Total Utang marang Modal tempus.com (TEM)|Rasio Utang marang Ekuitas QGEN|Utang marang Ekuitas Ionis Pharma IONS|Rasio Utang marang Ekuitas Repligen Inc. (RGEN)|Total Utang marang Modal RNA (Avidity Biosciences)|crisprtx.com - Total Utang marang Modal|GeneDx - Utang marang Ekuitas|RARE: Total Utang marang Modal|Utang marang Ekuitas BEAM|SRPT (Sarepta Corp) - Utang marang Modal|TWST - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi TXG|Intellia Therapeutics, Inc. (NTLA) - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi STOK (Stoke Therapeutics Inc)|BLFS: Utang marang Ekuitas|WVE - Utang marang Modal|Rasio Total Utang marang Ekuitas Maze Therapeutics Inc (MAZE)|SION - Rasio Kabeh Utang marang Dana Pribadi|Prime Medicine (PRME) - Total Utang marang Modal|Taysha Gene Therapies Inc (TSHA) - Utang marang Ekuitas|QURE: Total Utang marang Modal|Koefisien Total Utang marang Modal MGTX|REGENXBIO Inc. - Utang marang Ekuitas|Utang marang Modal solidbio.com SLDB|Rasio Total Utang marang Ekuitas Ocugen|Rasio Kabeh Utang marang Dana Pribadi Pacific Biosciences of California, Inc. PACB|Total Utang marang Modal BNTC (Benitec)|DSGN: Koefisien Total Utang marang Modal|Utang marang Ekuitas Rocket Pharmaceuticals|4dmoleculartherapeutics.com (FDMT) - Rasio Utang marang Ekuitas|Total Utang marang Modal LXEO|Rasio Total Utang marang Ekuitas Editas Medicine Inc (EDIT)|SLN (Silence Therapeutics Inc.) - Rasio Total Utang marang Ekuitas|Koefisien Total Utang marang Modal PRQR (proqr.com)|Utang marang Ekuitas CDXS (Codexis)|sangamo.com - Total Utang marang Modal|Utang marang Ekuitas Nautilus Biotechnology Inc (NAUT)|MGX: Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Precision BioSciences, Inc. DTIL|GBIO (Generation Bio) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas BOLD (Boundless Bio, Inc.)|Utang marang Modal Exicure Corp|Total Utang marang Modal Imunon, Inc. IMNN|Rasio Utang marang Ekuitas PHIO (phiopharma.com)|MBIO - Utang marang Ekuitas|Rasio Utang marang Ekuitas TransCode Therapeutics Inc. RNAZ|Bionano - Total Utang marang Modal|APDN: Total Utang marang Modal|BLUE: Utang marang Ekuitas|IPA (ImmunoPrecise Antibodies Ltd.) - Total Utang marang Modal|Utang marang Ekuitas OMGA (Omega)|Utang marang Modal OMIC|Regulus Therapeutics (RGLS) - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi SYRS (syros.com)|Utang marang Ekuitas Telesis Bio|TRACON Pharmaceuticals Inc. - Rasio Kabeh Utang marang Dana Pribadi|UBX (Unity Bio) - Utang marang Ekuitas